Raymond James & Associates’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-75,300
Closed -$136K 3896
2022
Q4
$136K Sell
75,300
-48,200
-39% -$1.89M ﹤0.01% 3565
2022
Q3
$61K Sell
123,500
-800
-0.6% -$32.1K ﹤0.01% 3683
2022
Q2
$291K Buy
124,300
+64,900
+109% +$2.78M ﹤0.01% 3254
2022
Q1
$196K Hold
59,400
﹤0.01% 3674
2021
Q4
$40K Hold
59,400
﹤0.01% 3974
2021
Q3
$14K Buy
59,400
+25,500
+75% +$957K ﹤0.01% 4035
2021
Q2
$27K Buy
+33,900
New +$1.33M ﹤0.01% 3960

Other funds holding BTI

Raymond James & Associates's BTI Position: Q3 2024 in Review

Raymond James & Associates increased its British American Tobacco (BTI) stake by 91% in Q3 2024, buying an estimated $74.3M and bringing the position to 4,359,526 shares worth $159M. The position accounts for 0.1% of the portfolio, ranked #182.

Raymond James & Associates first reported a position in BTI in Q2 2013 and has held it in 46 quarters since. 610 funds tracked by Wall St. Rank hold BTI as of Q3 2024.

  • Raymond James & Associates held 4,359,526 shares of British American Tobacco worth $159M as of Q3 2024.
  • Raymond James & Associates bought 2,079,761 British American Tobacco shares in Q3 2024, an estimated $74.3M.
  • British American Tobacco made up 0.1% of Raymond James & Associates's portfolio in Q3 2024, its #182 holding.
  • Raymond James & Associates first reported a position in British American Tobacco in Q2 2013 and has held it in 46 quarters since.
  • 610 funds tracked by Wall St. Rank held British American Tobacco as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.